OpenURL Connection Search

Select item for more details and to access through your institution.

Antidiabetic actions of a non-agonist PPAR? ligand blocking Cdk5-mediated phosphorylation.
Published in:
Nature, 2011, v. 477, n. 7365, p. 477, doi. 10.1038/nature10383
By:
- Jang Hyun Choi;
- Banks, Alexander S.;
- Kamenecka, Theodore M.;
- Busby, Scott A.;
- Chalmers, Michael J.;
- Kumar, Naresh;
- Kuruvilla, Dana S.;
- Youseung Shin;
- Yuanjun He;
- Bruning, John B.;
- Marciano, David P.;
- Cameron, Michael D.;
- Laznik, Dina;
- Jurczak, Michael J.;
- Schürer, Stephan C.;
- Vidović, Dušica;
- Shulman, Gerald I.;
- Spiegelman, Bruce M.;
- Griffin, Patrick R.
Publication type:
Article
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5.
Published in:
Nature, 2010, v. 466, n. 7305, p. 451, doi. 10.1038/nature09291
By:
- Jang Hyun Choi;
- Banks, Alexander S.;
- Estall, Jennifer L.;
- Kajimura, Shingo;
- Boström, Pontus;
- Laznik, Dina;
- Ruas, Jorge L.;
- Chalmers, Michael J.;
- Kamenecka, Theodore M.;
- Blüher, Matthias;
- Griffin, Patrick R.;
- Spiegelman, Bruce M.
Publication type:
Article
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α.
Published in:
2008
By:
- Arany, Zoltan;
- Foo, Shi-Yin;
- Ma, Yanhong;
- Ruas, Jorge L.;
- Bommi-Reddy, Archana;
- Girnun, Geoffrey;
- Cooper, Marcus;
- Laznik, Dina;
- Chinsomboon, Jessica;
- Rangwala, Shamina M.;
- Baek, Kwan Hyuck;
- Rosenzweig, Anthony;
- Spiegelman, Bruce M.
Publication type:
Letter
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.
Published in:
Nature, 2015, v. 517, n. 7534, p. 391, doi. 10.1038/nature13887
By:
- Banks, Alexander S.;
- McAllister, Fiona E.;
- Camporez, João Paulo G.;
- Zushin, Peter-James H.;
- Jurczak, Michael J.;
- Laznik-Bogoslavski, Dina;
- Shulman, Gerald I.;
- Gygi, Steven P.;
- Spiegelman, Bruce M.
Publication type:
Article
Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression.
Published in:
2009
By:
- Estall JL;
- Kahn M;
- Cooper MP;
- Fisher FM;
- Wu MK;
- Laznik D;
- Qu L;
- Cohen DE;
- Shulman GI;
- Spiegelman BM;
- Estall, Jennifer L;
- Kahn, Mario;
- Cooper, Marcus P;
- Fisher, Ffolliott Martin;
- Wu, Michele K;
- Laznik, Dina;
- Qu, Lishu;
- Cohen, David E;
- Shulman, Gerald I;
- Spiegelman, Bruce M
Publication type:
journal article
Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Expression.
Published in:
Diabetes, 2009, v. 58, n. 7, p. 1499, doi. 10.2337/db08-1571
By:
- Estall, Jennifer L.;
- Kahn, Mario;
- Cooper, Marcus P.;
- Fisher, Martin;
- Wu, Michele K.;
- Laznik, Dina;
- Qu, Lishu;
- Cohen, David E.;
- Shulman, Gerald I.;
- Spiegelman, Bruce M.
Publication type:
Article

Found: 6

Antidiabetic actions of a non-agonist PPAR? ligand blocking Cdk5-mediated phosphorylation.

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5.

HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α.

An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.

Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression.

Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Expression.